UW22168
OPEN TO ACCRUAL
Ph1 Study of ASP3082 in pts w/KRAS G12D Mutant Previously Treated Advanced/Metastatic Solid Tumors
UW26022
OPEN TO ACCRUAL
Ph III: Chemo +/- INCB161734 for KRAS G12D-Mutated Metastatic PDAC
UW26051
OPEN TO ACCRUAL
A Phase 2 Study of VS-7375 in Patients with KRAS G12D-Mutated Pancreatic Cancer